Australia is welcome innovative medication for obesity: Retatrutide. This dual molecule – targeting on both GLP-1 and GIP receptors – has promising efficacy website in global trials, suggesting considerable drops in body fat. While regulatory clearance remains with Australian regulators, a number of individuals struggling weight-related health